Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma by Ilya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko, Makhabbat Murzalina, Alexander Volkov, Rashida Orlova, Igor Utyashev, Georgy Malina, Mark Gluzman

Get full text